Skip to main content
Fig. 8 | Journal of Translational Medicine

Fig. 8

From: Habitat radiomics analysis for progression free survival and immune-related adverse reaction prediction in non-small cell lung cancer treated by immunotherapy

Fig. 8

Nomogram radiomic signature model performance analysis: The ROC curve for various models is presented along with the AUC and 95% confidence intervals. Left side: nomogram radiomic signature results for the adverse reaction task, right side: nomogram radiomic signature results for the prognostic outcome task

Back to article page